Kraig Biocraft Laboratories

Last updated
Kraig Biocraft Laboratories
Type Public
Industry Biotechnology
Founded2006;16 years ago (2006)
FounderKim Thompson
Headquarters Ann Arbor, Michigan
Key people
  • Kim Thompson
  • (Founder and CEO)
  • Jon Rice
  • (COO)
Website www.kraiglabs.com

Kraig Biocraft Laboratories, Inc. is an American biotechnology company headquartered in Ann Arbor, Michigan. It develops and manufactures recombinant spider silks and other high-performance polymers using spider silk gene sequences. [1] Their most notable fiber is dragon silk which has been demonstrated to be tougher than many fibers used in bullet proof vests. [2]

Contents

History

Kim Kraig Thompson, a retired lawyer, invented the protein expression platform in 2002, which would become the basis for Kraig Lab's work with spider silk. [3] He founded Kraig Biocraft Laboratories in April 2006 to develop and commercialize spider silks and other high-performance polymers gene and sequences using platform technology in combination with genetic engineering concepts. [4]

The original scientific work to reduce Thompson's invention to practice was performed in the biological laboratories of the University of Notre Dame. The University of Notre Dame was chosen in large part because the co-inventor of the PiggyBac transposon system, Malcom Fraser, was in residence there. This transposon was utilized by Kraig Labs and the University of Notre Dame to create the world’s first transgenic silkworm producing recombinant spider silk. This work was subsequently the subject of a peer-reviewed article in the publication of the National Academy of Sciences (PNAS). [5]

In 2011, Sigma-Aldrich started developing genetically modified silkworms in partnership with Kraig Biocraft Laboratories in order to produce spider silk. [1]

In 2019, the company's wholly owned subsidiary, Prodigy Textiles LLC, established production facility in Vietnam for the production of spider silk. [6] [7]

Research

The company's production platform is based upon genetic modification of the domesticated silk worm, Bombyx mori.

In 2020, the firm successfully developed a significantly more advanced technology platform. This utilized a non-CRISPR gene editing, large plasmid knock-in knock-out technology. The new platform allows for the creation of essentially pure spider silk. Other than the silkworm’s remaining specifically desired native silk protein elements, Kraig Labs is now able to produce nearly pure spider silk. [8] The knock-in knock-out technology allows Kraig Labs to work with very complex protein sequences in the silkworms, which are about four times more complex than published technologies. The company's Generation III Spider Silk Technology is purposed for specific customization. [8]

Kraig Labs originally used the PiggyBac Transposon plasmid vector that was developed in collaboration with the University of Notre Dame. [9] In all methods, specific sequences of spider DNA are inserted into the genetic makeup of the silkworm to create a silkworm that produces spider silk. That transgenic silkworm is then used as the basis for establishing a genetic line silkworms that also produce spider silk. [10] The firm is able to customize the sequences that it inserts into the silkworm, thus giving them the ability to customize the resulting silk thread’s strength, flexibility and possibly other properties. [11]

Related Research Articles

<span class="mw-page-title-main">Transposable element</span> Semiparasitic DNA sequence

A transposable element is a nucleic acid sequence in DNA that can change its position within a genome, sometimes creating or reversing mutations and altering the cell's genetic identity and genome size. Transposition often results in duplication of the same genetic material. Barbara McClintock's discovery of them earned her a Nobel Prize in 1983. Its importance in personalized medicine is becoming increasingly relevant, as well as gaining more attention in data analytics given the difficulty of analysis in very high dimensional spaces.

<i>Bombyx mori</i> Moth mainly used in the production of silk

The domestic silk moth, is an insect from the moth family Bombycidae. It is the closest relative of Bombyx mandarina, the wild silk moth. The silkworm is the larva or caterpillar of a silk moth. It is an economically important insect, being a primary producer of silk. A silkworm's preferred food are white mulberry leaves, though they may eat other mulberry species and even the osage orange. Domestic silk moths are entirely dependent on humans for reproduction, as a result of millennia of selective breeding. Wild silk moths are not as commercially viable in the production of silk.

<span class="mw-page-title-main">Spider silk</span> Protein fiber made by spiders

Spider silk is a protein fibre spun by spiders. Spiders use their silk to make webs or other structures, which function as sticky nets to catch other animals, or as nests or cocoons to protect their offspring, or to wrap up prey. They can also use their silk to suspend themselves, to float through the air, or to glide away from predators. Most spiders vary the thickness and stickiness of their silk for different uses.

<span class="mw-page-title-main">Molecular genetics</span> Scientific study of genes at the molecular level

Molecular genetics is a sub-field of biology that addresses how differences in the structures or expression of DNA molecules manifests as variation among organisms. Molecular genetics often applies an "investigative approach" to determine the structure and/or function of genes in an organism's genome using genetic screens. The field of study is based on the merging of several sub-fields in biology: classical Mendelian inheritance, cellular biology, molecular biology, biochemistry, and biotechnology. Researchers search for mutations in a gene or induce mutations in a gene to link a gene sequence to a specific phenotype. Molecular genetics is a powerful methodology for linking mutations to genetic conditions that may aid the search for treatments/cures for various genetics diseases.

P elements are transposable elements that were discovered in Drosophila as the causative agents of genetic traits called hybrid dysgenesis. The transposon is responsible for the P trait of the P element and it is found only in wild flies. They are also found in many other eukaryotes.

A transgene is a gene that has been transferred naturally, or by any of a number of genetic engineering techniques, from one organism to another. The introduction of a transgene, in a process known as transgenesis, has the potential to change the phenotype of an organism. Transgene describes a segment of DNA containing a gene sequence that has been isolated from one organism and is introduced into a different organism. This non-native segment of DNA may either retain the ability to produce RNA or protein in the transgenic organism or alter the normal function of the transgenic organism's genetic code. In general, the DNA is incorporated into the organism's germ line. For example, in higher vertebrates this can be accomplished by injecting the foreign DNA into the nucleus of a fertilized ovum. This technique is routinely used to introduce human disease genes or other genes of interest into strains of laboratory mice to study the function or pathology involved with that particular gene.

<span class="mw-page-title-main">Mobile genetic elements</span> DNA sequence whose position in the genome is variable

Mobile genetic elements (MGEs) sometimes called selfish genetic elements are a type of genetic material that can move around within a genome, or that can be transferred from one species or replicon to another. MGEs are found in all organisms. In humans, approximately 50% of the genome is thought to be MGEs. MGEs play a distinct role in evolution. Gene duplication events can also happen through the mechanism of MGEs. MGEs can also cause mutations in protein coding regions, which alters the protein functions. These mechanisms can also rearrange genes in the host genome generating variation. These mechanism can increase fitness by gaining new or additional functions. An example of MGEs in evolutionary context are that virulence factors and antibiotic resistance genes of MGEs can be transported to share genetic code with neighboring bacteria. However, MGEs can also decrease fitness by introducing disease-causing alleles or mutations. The set of MGEs in an organism is called a mobilome, which is composed of a large number of plasmids, transposons and viruses.

The Tn3 transposon is a 4957 base pair mobile genetic element, found in prokaryotes. It encodes three proteins:

In molecular cloning and biology, a gene knock-in refers to a genetic engineering method that involves the one-for-one substitution of DNA sequence information in a genetic locus or the insertion of sequence information not found within the locus. Typically, this is done in mice since the technology for this process is more refined and there is a high degree of shared sequence complexity between mice and humans. The difference between knock-in technology and traditional transgenic techniques is that a knock-in involves a gene inserted into a specific locus, and is thus a "targeted" insertion. It is the opposite of gene knockout.

<span class="mw-page-title-main">Knockout rat</span> Type of genetically engineered rat

A knockout rat is a genetically engineered rat with a single gene turned off through a targeted mutation used for academic and pharmaceutical research. Knockout rats can mimic human diseases and are important tools for studying gene function and for drug discovery and development. The production of knockout rats was not economically or technically feasible until 2008.

A dermal patch or skin patch is a medicated adhesive patch that is placed on the skin to deliver a medication into the skin. This is in contrast to a transdermal patch, which delivers the medication through the skin and into the bloodstream.

<span class="mw-page-title-main">Genetically modified animal</span> Animal that has been genetically modified

Genetically modified animals are animals that have been genetically modified for a variety of purposes including producing drugs, enhancing yields, increasing resistance to disease, etc. The vast majority of genetically modified animals are at the research stage while the number close to entering the market remains small.

Transposons are semi-parasitic DNA sequences which can replicate and spread through the host's genome. They can be harnessed as a genetic tool for analysis of gene and protein function. The use of transposons is well-developed in Drosophila and in Thale cress and bacteria such as Escherichia coli.

<span class="mw-page-title-main">Genetically modified mammal</span>

Genetically modified mammals are mammals that have been genetically engineered. They are an important category of genetically modified organisms. The majority of research involving genetically modified mammals involves mice with attempts to produce knockout animals in other mammalian species limited by the inability to derive and stably culture embryonic stem cells.

<span class="mw-page-title-main">Molecular cloning</span> Set of methods in molecular biology

Molecular cloning is a set of experimental methods in molecular biology that are used to assemble recombinant DNA molecules and to direct their replication within host organisms. The use of the word cloning refers to the fact that the method involves the replication of one molecule to produce a population of cells with identical DNA molecules. Molecular cloning generally uses DNA sequences from two different organisms: the species that is the source of the DNA to be cloned, and the species that will serve as the living host for replication of the recombinant DNA. Molecular cloning methods are central to many contemporary areas of modern biology and medicine.

The PiggyBac (PB) transposon is a mobile genetic element that efficiently transposes between vectors and chromosomes via a "cut and paste" mechanism. During transposition, the PB transposase recognizes transposon-specific inverted terminal repeat sequences (ITRs) located on both ends of the transposon vector and efficiently moves the contents from the original sites and integrates them into TTAA chromosomal sites. The powerful activity of the PiggyBac transposon system enables genes of interest between the two ITRs in the PB vector to be easily mobilized into target genomes. The TTAA-specific transposon piggyBac is rapidly becoming a highly useful transposon for genetic engineering of a wide variety of species, particularly insects. They were discovered in 1989 by Malcolm Fraser at the University of Notre Dame.

<span class="mw-page-title-main">History of genetic engineering</span> Aspect of history

Genetic engineering is the science of manipulating genetic material of an organism. The first artificial genetic modification accomplished using biotechnology was transgenesis, the process of transferring genes from one organism to another, first accomplished by Herbert Boyer and Stanley Cohen in 1973. It was the result of a series of advancements in techniques that allowed the direct modification of the genome. Important advances included the discovery of restriction enzymes and DNA ligases, the ability to design plasmids and technologies like polymerase chain reaction and sequencing. Transformation of the DNA into a host organism was accomplished with the invention of biolistics, Agrobacterium-mediated recombination and microinjection. The first genetically modified animal was a mouse created in 1974 by Rudolf Jaenisch. In 1976 the technology was commercialised, with the advent of genetically modified bacteria that produced somatostatin, followed by insulin in 1978. In 1983 an antibiotic resistant gene was inserted into tobacco, leading to the first genetically engineered plant. Advances followed that allowed scientists to manipulate and add genes to a variety of different organisms and induce a range of different effects. Plants were first commercialized with virus resistant tobacco released in China in 1992. The first genetically modified food was the Flavr Savr tomato marketed in 1994. By 2010, 29 countries had planted commercialized biotech crops. In 2000 a paper published in Science introduced golden rice, the first food developed with increased nutrient value.

<span class="mw-page-title-main">Genetic engineering techniques</span> Methods used to change the DNA of organisms

Genetic engineering techniques allow the modification of animal and plant genomes. Techniques have been devised to insert, delete, and modify DNA at multiple levels, ranging from a specific base pair in a specific gene to entire genes. There are a number of steps that are followed before a genetically modified organism (GMO) is created. Genetic engineers must first choose what gene they wish to insert, modify, or delete. The gene must then be isolated and incorporated, along with other genetic elements, into a suitable vector. This vector is then used to insert the gene into the host genome, creating a transgenic or edited organism.

<span class="mw-page-title-main">Reverse genetics</span> Method in molecular genetics

Reverse genetics is a method in molecular genetics that is used to help understand the function(s) of a gene by analysing the phenotypic effects caused by genetically engineering specific nucleic acid sequences within the gene. The process proceeds in the opposite direction to forward genetic screens of classical genetics. While forward genetics seeks to find the genetic basis of a phenotype or trait, reverse genetics seeks to find what phenotypes are controlled by particular genetic sequences.

<span class="mw-page-title-main">Dragon silk</span>

Dragon silk is a material created by Kraig Biocraft Laboratories of Ann Arbor, Michigan from genetically modified silkworms to create body armor. Dragon silk combines the elasticity and strength of spider silk. It has the tensile strength as high as 1.79 gigapascals and the elasticity above 38% exceeding the maximum reported features of the spider silk. It is reported that dragon silk is more flexible than the Monster silk and stronger than the "Big Red, recombinant spider silk designed for increased strength.

References

  1. 1 2 Kelsey Volkmann (April 11, 2012). "Sigma-Aldrich to make modified silk worms". St. Louis Business Journal.(subscription required)
  2. "Spider Silk Production Breakthrough from Kraig Biocraft Laboratories | Kraig Biocraft Laboratories". 30 May 2019.
  3. "Original Provisional Patent | Kraig Biocraft Laboratories". 8 May 2020.
  4. "Kraig Biocraft Laboratories Announces Patent Filing on Artificial Spider Silk Breakthrough | Kraig Biocraft Laboratories". 30 September 2010.
  5. Teulé, Florence; Miao, Yun-Gen; Sohn, Bong-Hee; Kim, Young-Soo; Hull, J. Joe; Fraser, Malcolm J.; Lewis, Randolph V.; Jarvis, Donald L. (17 January 2012). "Silkworms transformed with chimeric silkworm/spider silk genes spin composite silk fibers with improved mechanical properties". Proceedings of the National Academy of Sciences. 109 (3): 923–928. Bibcode:2012PNAS..109..923T. doi: 10.1073/pnas.1109420109 . PMC   3271896 . PMID   22215590.
  6. "Full speed ahead in Vietnam".
  7. Friedman, Arthur (July 27, 2021). "Kraig Biocraft Hits Vietnam Covid Snag".
  8. 1 2 "Kraig Biocraft Laboratories achieves Knock-in Knock-out Success to create nearly Pure Spider Silk | Kraig Biocraft Laboratories". 17 April 2020.
  9. "Kraig Biocraft Laboratories, Inc. Gears Up to Double the Number of Genetic Insertions Performed | Kraig Biocraft Laboratories". 12 May 2009.
  10. Grossman, Lisa (October 4, 2010). "Mutant Worms Produce Piles of Spider Silk". Wired via www.wired.com.
  11. "Transgenic Worms Make Tough Fibers". MIT Technology Review.